Ozone Therapy Could Improve Sepsis-induced Acute Lung Injury
Researchers found that medical ozone therapy can improve lung function in mice with sepsis-induced acute lung injury.
Tag: sepsis
All
Latest
Ozone Therapy Could Improve Sepsis-induced Acute Lung Injury
Researchers found that medical ozone therapy can improve lung function in mice with sepsis-induced acute lung injury.
Read More
FDA Grants Breakthrough Designation to Sepsis Risk Assessment Test
The FDA has granted Breakthrough Device Designation to a sepsis risk assessment test designed to support rapid clinical decisions.
Read More
$100M Funding to Boost Rollout of FDA-Cleared Sepsis TestÂ
The funding will accelerate the rollout of a rapid diagnostic test that helps emergency departments quickly identify and treat sepsis.
Read More
Sepsis Cases Rise 72% Driven by Pandemic
The COVID-19 pandemic led to a noticeable rise in sepsis-related hospitalizations, hospital costs, and in-hospital mortality, particularly for patients with a COVID-19 diagnosis.
Read More
FDA Clears Test for Early Sepsis Detection
The newly cleared test detects sepsis earlier than current standards by measuring levels of the pancreatic stone protein biomarker.
Read More
AI Sepsis Risk Prediction Tool Seeks Doctor Input to Boost Accuracy
The AI tool actively involves clinicians by identifying missing patient data and suggesting the most critical information needed to improve sepsis risk predictions.
Read More
FDA Clears bioMérieux Vitek Reveal AST System
bioMérieux received US FDA 510(k) clearance for its Vitek Reveal AST System, which reports results directly from positive blood cultures.
Read More
Acetaminophen Reduces Organ Injury and ARDS in Sepsis Patients
In patients most at risk for organ damage, the drug lessened the need for assisted ventilation and showed a slight decrease in mortality.Â
Read More
Hospital Diversity Tied to Higher Mechanical Ventilation Mortality
Patients receiving mechanical ventilation for pneumonia or sepsis have higher odds of death in hospitals with greater racial diversity.
Read More
Roche to Distribute Sepsis ImmunoScore from Prenosis
Roche will commercially distribute Prenosis Inc’s Sepsis ImmunoScore, the first-ever FDA De Novo authorized AI diagnostic tool for sepsis.
Read More
Azithromycin a Cost-Saving Treatment for Reducing Maternal Sepsis, Death or Infection
Administering azithromycin to pregnant women who deliver vaginally is a cost-saving treatment for reducing maternal sepsis, death or infection in developing countries.
Read More
Using AI Helped Predict Sepsis, Reduced Mortality
An AI algorithm used in emergency departments at UC San Diego Health allowed clinicians to quickly predict sepsis infection in high-risk patients and reduce mortality, according to a new study, published in npj Digital Medicine.
Read More
Phoenix Criteria for Pediatric Sepsis Based on Organ Dysfunction
The Phoenix criteria define sepsis as severe response to infection involving organ dysfunction, as opposed to an earlier focus on systemic inflammation.
Read More
SCCM Project Aims to Decrease Sepsis Deaths in Low-Resource Settings
An initiative from the Society of Critical Care Medicine aims to decrease sepsis mortality in low-resource settings, where as much as 84% of sepsis-related deaths occur.
Read More
Considering Individual Sensitivity to Hypoxia
Even when the oxygen level is normal, inflammation and the reaction to hypoxia are connected; the key is individual sensitivity to hypoxia.
Read More
Sepsis Cases on the Rise in 2023
Northwestern Medicine’s Delnor Hospital has seen a 10% increase in the total number of sepsis patients and a 33% increase in patients who arrived in severe sepsis in the last fiscal year.
Read More
Single-dose Azithromycin Prevents Postpartum Sepsis, Mortality
A single oral dose of azithromycin can reduce the risk of postpartum sepsis and death among women who deliver vaginally by one-third, according to a large multi-country published in the New England Journal of Medicine.
Read More
Sepsis Treatment Strategies Comparable
There were no significant differences in 90-day mortality rates between two common treatment strategies for sepsis, according to a phase 3 clinical trial published in the NEJM.
Read More
Pathogenomix Rapid Test Granted Breakthrough Device Status
Pathogenomix Inc’s Patho-Seq is designed for the rapid detection and identification of bacteria for a broad list of clinical conditions and sample types, including sepsis from whole blood samples and bacterial meningitis from CSF.
Read More
Turn Medical Launches Pronova-O2 Automated Prone Therapy System
Turn Medical has released a novel prone positioning device, the Pronova-O2Â Automated Prone Therapy System.
Read More
Engineering Nanoparticles for Medication Delivery to the Lungs
Bioengineers are developing a medication delivery method using nanoparticles coated in a cell membrane that’s been genetically engineered to look for and bind to inflamed lung cells.
Read More
Children with Sepsis from Low-income Neighborhoods Have Greater Length of Hospital Stay
Children being treated for sepsis stayed in the hospital longer if they lived in low-income ZIP codes compared to those who were from high-income ZIP codes, according to research at SCCM 2021.
Read More
Virtual Post-Sepsis Recovery Program May Also Help Recovering COVID-19 Patients
A virtual recovery program for sepsis patients that may also help post-COVID-19 patients and survivors of other serious illnesses.
Read More
Study: Severe Sepsis Predicted by Common Protein
A sugar-binding protein could fuel inflammation and worsen sepsis, a disease that kills more than 270,000 people every year in the US alone.
Read More